Your browser doesn't support javascript.
loading
Real-world experience of combined treatment with azacitidine and romidepsin in patients with peripheral T-cell lymphoma.
Kalac, Matko; Jain, Salvia; Tam, Constantine S; Xiao, Zhengrui; Montanari, Francesca; Kanakry, Jennifer; Huber, Bryan D; Goldfinger, Mendel; O'Connor, Owen A; Marchi, Enrica.
Affiliation
  • Kalac M; Department of Hematology and Oncology, Icahn School of Medicine at Mount Sinai, New York, NY.
  • Jain S; Department of Hematology and Oncology, University of California, Irvine, CA.
  • Tam CS; Department of Medicine, Massachusetts General Hospital, Boston, MA.
  • Xiao Z; Alfred Hospital and Central Clinical School, Monash University, Melbourne, VIC, Australia.
  • Montanari F; Department of Medicine, Albert Einstein College of Medicine, New York, NY.
  • Kanakry J; Department of Hematology, Yale University Cancer Center, Greenwich, CT.
  • Huber BD; Experimental Transplantation & Immunotherapy Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD.
  • Goldfinger M; Blood and Marrow Transplant/Acute Leukemia Program, Intermountain Medical Group, Salt Lake City, UT.
  • O'Connor OA; Department of Medicine, Albert Einstein College of Medicine, New York, NY.
  • Marchi E; Division of Hematology and Oncology, University of Virginia Cancer Center, Charlottesville, VA.
Blood Adv ; 7(14): 3760-3763, 2023 07 25.
Article in En | MEDLINE | ID: mdl-36790924

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Lymphoma, T-Cell, Peripheral / Depsipeptides Limits: Humans Language: En Journal: Blood Adv Year: 2023 Document type: Article Country of publication: United States

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Lymphoma, T-Cell, Peripheral / Depsipeptides Limits: Humans Language: En Journal: Blood Adv Year: 2023 Document type: Article Country of publication: United States